Inhibition of high glucose-induced VEGF and ICAM-1 expression in human retinal pigment epithelium cells by targeting ILK with small interference RNA

The aim of this study was to investigate the change of Integrin-linked kinase (ILK) expression of human retinal pigment epithelium (RPE) cells in response to high glucose, and the effect of targeting ILK with small interference RNA (siRNA) on the high glucose-induced expression of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1). The ILK mRNA and protein expression in human RPE cells were analyzed with RT-PCR and western blot after exposure to 5.5, 30, 40, 50 mM glucose, or 5.5 mM glucose + 45.5 mM mannitol for 48 h. The expression of VEGF and ICAM-1 was also determined. Cells were treated with ILK siRNA, to determine the effect of ILK on VEGF and ICAM-1 expression following treatment with high glucose. High concentrations of glucose significantly up-regulated ILK mRNA and protein expression, and the ILK expression increased along with the glucose concentration. The changes of VEGF and ICAM-1 expression were similar to that of ILK expression. Knocking down ILK gene expression with siRNA inhibited the elevation of VEGF and ICAM-1 induced by high glucose treatment. These results suggested that ILK was involved in the response of RPE cells to high glucose and may therefore play a role in the pathogenesis of diabetic ophthalmology.

[1]  S. Dedhar,et al.  Integrin-linked Kinase Regulates Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression in an NF-κB-dependent Manner* , 2002, The Journal of Biological Chemistry.

[2]  M. Gleave,et al.  Regulation of tumor angiogenesis by integrin-linked kinase (ILK). , 2004, Cancer cell.

[3]  Peng Zhou,et al.  Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy. , 2008, Experimental eye research.

[4]  Ming-ming Li,et al.  Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression. , 2008, Biological & pharmaceutical bulletin.

[5]  G. Mills,et al.  Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. , 2007, Archives of otolaryngology--head & neck surgery.

[6]  S. Dedhar,et al.  Regulation of Protein Kinase B/Akt-Serine 473 Phosphorylation by Integrin-linked Kinase , 2001, The Journal of Biological Chemistry.

[7]  M. Matsumura,et al.  Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. , 2006, Diabetes research and clinical practice.

[8]  Wei Wang,et al.  17-AAG, a Hsp90 inhibitor, attenuates the hypoxia-induced expression of SDF-1α and ILK in mouse RPE cells , 2010, Molecular Biology Reports.

[9]  J. Osredkar,et al.  K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes , 2008, Clinical & experimental ophthalmology.

[10]  K. Makino,et al.  Upregulation of IKKα/IKKβ by integrin-linked kinase is required for HER2/neu-induced NF-κB antiapoptotic pathway , 2004, Oncogene.

[11]  Seock-Won Youn,et al.  Regulation of Endothelial Cell and Endothelial Progenitor Cell Survival and Vasculogenesis by Integrin-Linked Kinase , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[12]  K. Yamashiro,et al.  VEGF164 is proinflammatory in the diabetic retina. , 2003, Investigative ophthalmology & visual science.

[13]  G. Mills,et al.  Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma , 2005, Molecular Cancer Therapeutics.

[14]  R. Cardiff,et al.  Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice , 2001, Oncogene.

[15]  Elizabeth D. Wederell,et al.  Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. , 2008, Cancer research.

[16]  D. Huntsman,et al.  Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK) , 2008, Molecular Cancer Therapeutics.

[17]  S. Dedhar,et al.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK , 2005, Nature Reviews Cancer.

[18]  K. Makino,et al.  Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway. , 2004, Oncogene.

[19]  JinHur,et al.  Integrin-Linked Kinase, a Hypoxia-Responsive Molecule, Controls Postnatal Vasculogenesis by Recruitment of Endothelial Progenitor Cells to Ischemic Tissue , 2006 .

[20]  Seock-Won Youn,et al.  Integrin-Linked Kinase, a Hypoxia-Responsive Molecule, Controls Postnatal Vasculogenesis by Recruitment of Endothelial Progenitor Cells to Ischemic Tissue , 2006, Circulation.

[21]  D. Lefer,et al.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.

[22]  A. Yoshida,et al.  Permeability of the blood-ocular barrier in adolescent and adult diabetic patients. , 1993, The British journal of ophthalmology.

[23]  J. Nadler,et al.  Inflammatory mechanisms of diabetic complications , 2007, Current diabetes reports.

[24]  Li Dong,et al.  Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells , 2009, Molecular Biology Reports.

[25]  Feng Yan,et al.  Up-regulation of integrin-linked kinase in the streptozotocin-induced diabetic rat retina , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  K Miyamoto,et al.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.